Stem cell-based implants successfully secrete insulin in patients with type 1 diabetes
Fecha:
Diciembre 2, 2021
Fuente:
Cell Press
Resumen:
Interim results from a multicenter clinical trial demonstrate insulin secretion from engrafted cells in patients with type 1 diabetes. The safety, tolerability, and efficacy of the implants, which consisted of pancreatic endoderm cells derived from human pluripotent stem cells (PSC), were tested in 26 pacientes. While the insulin secreted by the implants did not have clinical effects in the patients, the data are the first reported evidence of meal-regulated insulin secretion by differentiated stem cells in human patients.
Interesado en saber si los programas clínicos actuales, desarrollos de investigacion, o enfoques terapéuticos emergentes pueden ser relevantes para su situación?
Información educativa y de investigación únicamente.. Las decisiones médicas individuales deben tomarse en consulta con profesionales sanitarios cualificados..
